Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

The Pathologist / Issues / 2025 / June / New Scoring Methods in CRC Prognosis
Oncology Histology Oncology Digital and computational pathology Screening and monitoring Research and Innovations Microscopy and imaging

What's the Best Scoring Method in CRC Prognosis?

Study of three systems finds that a simple tumor growth pattern scoring method independently predicts colon cancer–specific survival.

06/12/2025 News 1 min read

Share

A visual classification method for tumor growth patterns at the invasive front—specifically the tumor growth pattern method—was the only scoring system independently associated with colon cancer–specific survival in multivariable analysis, according to a recent study.

The researchers conducted a retrospective cohort study to evaluate the reproducibility and prognostic utility of three histopathological scoring methods at the invasive tumor front in stage I to III colorectal cancer (CRC). Published in The Journal of Pathology Clinical Research, the study analyzed hematoxylin and eosin–stained sections from 538 patients treated at Glasgow Royal Infirmary between 1997 and 2013.

The scoring systems assessed were the Karamitopoulou method (percentage-based infiltration in 5 percent increments), the Taskin method (five-point scale evaluating tumor demarcation and infiltrative clusters), and the tumor growth pattern (TGP) classification (categorizing patterns as pushing, intermediate, or infiltrative). Interobserver reproducibility was highest for the Karamitopoulou and TGP methods, with intraclass correlation coefficients of 0.63 and 0.79 for Karamitopoulou and weighted kappa of 0.78 for TGP. The Taskin method demonstrated lower agreement (weighted kappa of 0.31 and 0.27).

Among the 538 patients, 65 percent were classified with high infiltrative scores by the Karamitopoulou method (greater than 50 percent), and 67 percent received scores of 4 to 5 using the Taskin method. The TGP classification identified 44 percent of tumors as infiltrative, 31 percent as pushing, and 25 percent as intermediate. Higher scores across all methods were associated with adverse clinicopathological features, including advanced T stage, N stage, venous invasion, and peritoneal involvement.

In Kaplan–Meier analysis, infiltrative tumors classified via the TGP method were associated with reduced CRC-specific survival. On multivariable Cox regression, the TGP method independently predicted colon cancer–specific survival, while the Karamitopoulou and Taskin methods did not retain statistical significance after adjusting for tumor budding and other variables.

The TGP method demonstrated additional prognostic value among patients with low tumor budding and was reported by the researchers as practical, reproducible, and prognostically relevant for colon cancer.

Newsletters

Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Your Newest Colleague?
Histology
Your Newest Colleague?

January 6, 2022

1 min read

The need for AI-based end-to-end biomarkers in oncology

Biospecimen Access For Biotechs
Histology
Biospecimen Access For Biotechs

February 14, 2022

1 min read

Quality, provenance, and “taking pot luck”

Case of the Month
Histology
Case of the Month

February 21, 2022

1 min read

The Art of the Laboratory
Histology
The Art of the Laboratory

March 25, 2022

1 min read

For the seventh time, we asked you to share the images you think capture the most beautiful, educational, or amusing aspects of pathology – and you delivered. Welcome to our gallery tour of the most visually striking discipline in medicine!

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.